Section 246-240-281 - Training for ophthalmic use of strontium-90Except as provided in WAC 246-240-078, the licensee shall require the authorized user of strontium-90 for ophthalmic radiotherapy to be a physician who:
(1) Is an authorized user under WAC 246-240-278 or equivalent agreement state or NRC requirements; or(2)(a) Has completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiotherapy. The training must include: (i) Radiation physics and instrumentation;(ii) Radiation protection;(iii) Mathematics pertaining to the use and measurement of radioactivity; and(iv) Radiation biology; and(b) Supervised clinical training in ophthalmic radiotherapy under the supervision of an authorized user at a medical institution that includes the use of strontium-90 for the ophthalmic treatment of five individuals. This supervised clinical training must involve:
(i) Examination of each individual to be treated;(ii) Calculation of the dose to be administered;(iii) Administration of the dose; and(iv) Follow up and review of each individual's case history; and(c) Has obtained written attestation, signed by a preceptor authorized user who meets the requirements in WAC 246-240-078, 246-240-278, 246-240-281, or equivalent agreement state or NRC requirements, that the individual has satisfactorily completed the requirements in (a) and (b) of this subsection and is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use.Wash. Admin. Code § 246-240-281
Amended by WSR 22-19-084, Filed 9/20/2022, effective 10/21/2022Statutory Authority: RCW 70.98.050. 11-03-068, § 246-240-281, filed 1/18/11, effective 2/18/11; 06-05-019, § 246-240-281, filed 2/6/06, effective 3/9/06.